Abstract
Hepcidin is a small protein involved in iron metabolism that also exhibits antibacterial and antifungal activities. Since its discovery in 2000, hepcidin has been extensively studied in many research centers. Usage of natural and synthetic hepcidin inhibitors can be applied as a powerful therapeutic tool that targets multiple types of anemia. In addition, the protein itself has a potential to placate increased absorption of iron in patients with β-thalassemia. Previous studies have characterized mechanisms of hepcidin synthesis as well as its biological activity, however methods enabling estimation of its concentration in biological materials remain obscure. The physiological role of hepcidin in iron metabolism as well as methods of its determination in serum and urine samples are described in this paper. Furthermore, the possible role of hepcidin and its molecular antagonists in health improvement is considered.
Keywords: Iron, Hepcidin, Hepcidin assays, ELISA, SELDI-TOF-MS, Biological activity, Antibacterial, Antifungal, Hepcidin inhibitors, thalassemia
Current Pharmaceutical Analysis
Title: Hepcidin: Biological Activity, Analytical Methods in Biological Fluids, Clinical Applications and Antagonists. A Short Review
Volume: 7 Issue: 3
Author(s): Artur Slomka, Marcin Koba, Arleta Kulwas and Ewa Zekanowska
Affiliation:
Keywords: Iron, Hepcidin, Hepcidin assays, ELISA, SELDI-TOF-MS, Biological activity, Antibacterial, Antifungal, Hepcidin inhibitors, thalassemia
Abstract: Hepcidin is a small protein involved in iron metabolism that also exhibits antibacterial and antifungal activities. Since its discovery in 2000, hepcidin has been extensively studied in many research centers. Usage of natural and synthetic hepcidin inhibitors can be applied as a powerful therapeutic tool that targets multiple types of anemia. In addition, the protein itself has a potential to placate increased absorption of iron in patients with β-thalassemia. Previous studies have characterized mechanisms of hepcidin synthesis as well as its biological activity, however methods enabling estimation of its concentration in biological materials remain obscure. The physiological role of hepcidin in iron metabolism as well as methods of its determination in serum and urine samples are described in this paper. Furthermore, the possible role of hepcidin and its molecular antagonists in health improvement is considered.
Export Options
About this article
Cite this article as:
Slomka Artur, Koba Marcin, Kulwas Arleta and Zekanowska Ewa, Hepcidin: Biological Activity, Analytical Methods in Biological Fluids, Clinical Applications and Antagonists. A Short Review, Current Pharmaceutical Analysis 2011; 7 (3) . https://dx.doi.org/10.2174/157341211796353309
DOI https://dx.doi.org/10.2174/157341211796353309 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Human Ghrelin: A Gastric Hormone with Cardiovascular Properties
Current Pharmaceutical Design Ex Vivo and In Vivo Approaches to Study Mechanisms of Cardioprotection Targeting Ischemia/Reperfusion (I/R) Injury: Useful Techniques for Cardiovascular Drug Discovery
Current Drug Discovery Technologies Biofilms: An Extra Hurdle for Effective Antimicrobial Therapy
Current Pharmaceutical Design MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Cardiac Disease
Recent Patents on Biomarkers Recent Applications of Benzimidazole as a Privileged Scaffold in Drug Discovery
Mini-Reviews in Medicinal Chemistry Fluoride Interactions: From Molecules to Disease
Current Signal Transduction Therapy Safety Limits of Antidepressant Use Plus Combinations: Focus on Cardiovascular Function
Current Drug Metabolism Beta3-Adrenoreceptors in Cardiovasular Diseases: New Roles for an “Old” Receptor
Current Drug Delivery Clinical and Molecular Genetic Aspects of Hypertrophic Cardiomyopathy
Current Cardiology Reviews Mechanisms Underlying the Hepatotoxic Effects of Ecstasy
Current Pharmaceutical Biotechnology Treating Arterial Stiffness in Young and Elderly Patients with the Metabolic Syndrome
Current Pharmaceutical Design Proteinase-Activated Receptor 2 (PAR2): A Challenging New Target for Treatment of Vascular Diseases
Current Pharmaceutical Design The In Vitro and In Vivo Inhibitory Effect of Dehydroaltenusin: A Specific Inhibitor of Mammalian DNA Polymerase α
Current Bioactive Compounds Towards the Development of Anticancer Drugs from Andrographolide: Semisynthesis, Bioevaluation, QSAR Analysis and Pharmacokinetic Studies
Current Topics in Medicinal Chemistry Characteristics Other than the Diagnostic Criteria Associated with Metabolic Syndrome: An Overview
Current Vascular Pharmacology Micronutrient Biofortification in Rice through New Breeding Techniques (NBTs): Bangladesh Perspective
Current Nutraceuticals Treatment of the Cheyne-Stokes Breathing Pattern in Patients with Congestive Heart Failure: State of the Art
Current Respiratory Medicine Reviews Asthma-COPD Overlap: A more Simplistic Approach
Current Respiratory Medicine Reviews Glucagon Like Peptides-1 Modulators as Newer Target for Diabetes
Current Drug Targets Effects of Nicotine on the Cardiovascular System
Vascular Disease Prevention (Discontinued)